IL19 and psoriasis: They also reported a reduction in IL-19 concentration levels to normal after skin improvement in both conditions following biological therapy (Ixekizumab for psoriasis and Baricitinib for atopic dermatitis) [24].IL-19 has been shown to be expressed in inflammatory conditions in various diseases [14, 16, 24].